BIIB022 / Biogen 
Welcome,         Profile    Billing    Logout  
 19 Diseases   0 Trials   0 Trials   3 News 
  • ||||||||||  BIIB022 / Biogen
    Trial completion, Metastases:  Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) (clinicaltrials.gov) -  Sep 28, 2011   
    P1,  N=40, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed